Advertisement
Home Tags Cancer: Mouth

Tag: Cancer: Mouth

For patients with oropharynx cancer

Mortality Risk in Oropharynx Cancer Varies Based on HPV Status

Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality
The checkpoint inhibitor pembrolizumab prolongs survival in patients with certain head and neck cancers

Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer

Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Nonsteroidal anti-inflammatory drugs are correlated with better overall survival in patients with head and neck squamous cell carcinoma

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients

Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
Delaying time to treatment initiation beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence

Delaying Treatment Worsens Head, Neck Cancer Outcomes

Findings show that survival declines, recurrence increases with delays of more than 60 days
Despite a recent dental visit

Minority, Low-Income Individuals Less Likely to Receive Oral Cancer Screening

Education level, insurance type also may affect likelihood of oral cancer screening at dental visit
Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer

Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer

Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
As distant metastasis in head and neck squamous cell carcinoma is a rare event

Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation

Since distant metastasis only seen in 3 percent of head, neck cancers, chest CT more cost-effective
In patients with head and neck cancer

Mental Health Disorders Up After Head & Neck Cancer Diagnosis

Women, patients with history of tobacco use, alcohol use have significantly higher odds of MHDs
There may be a significant

9/11 Responders May Have Higher Head, Neck Cancer Risk

Authors call for ongoing monitoring, treatment of those initially exposed
Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer

Persistent Opioid Use High in Head, Neck Cancer Patients

Opioid use before treatment, tobacco use are risk factors for ongoing opioid use